Brian Schultz is a PMI-certified project manager with over 15 years of experience in project and program management within the biopharma sector, focusing on product development and commercialization. They began their career as a chemist and advanced through various roles, including significant positions at Amylin Pharmaceuticals, Zentalis Pharmaceuticals, and Crinetics Pharmaceuticals, where they currently serve as Director of Program & Portfolio Management. Schultz successfully led numerous projects resulting in FDA and EU approvals and has extensive expertise in regulatory submissions, CMC, and process optimization. They hold a BS in Biochemistry from the University of Dayton and additional qualifications in project management from the University of California, San Diego.
This person is not in any teams